I have been talking about the need to increase the funding levels for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) for a long period. This program has proven itself to be the single most valuable government funded prostate cancer research program. The program is designed to fund research projects that [...]
An article in today's New York Times about obtaining drugs under the compassionate use clause boiled my blood. I am not usually one without words, but this story has left me speechless, or wordless. I can not add anything to the story, it speaks for itself and makes me cry. Joel T Nowak MA, MSW
Shocking news, under the President Obama's latest budget request, the prostate cancer program at CDC would receive only a 0.23% increase. The FDA would receive an appropriation of $2.35 billion, an increase of $295 million (14.4%), once again prostate cancer has been left in the dust! Joel T Nowak MA, MSW
A letter from Sens. Tim Johnson (D-SD) and Mike Crapo (R-ID) is circulating in the Senate now and will be sent to the Defense Appropriations Subcommittee on Friday, April 24. Contact your Senators today and ask them to sign the Johnson-Crapo Appropriations letter to increase research funding for prostate cancer at the Department of Defense. [...]
At the American Association for Cancer Research 100th Annual Meeting 2009 in Denver, National Cancer Institute (NCI) Director John E. Niederhuber, M.D., announced major details, such as funding more grants, development of a platform for personalized cancer care, and an accelerated cancer genetics program, that will move cancer research forward in this new economic environment. [...]